Posted On: 09/19/2014 9:10:52 AM
Post# of 30066
Old news, but is good to see a news page other than Amarantus.
“We are quite excited about the possibilities for MANF,” said Rong Wen, M.D., Ph.D., professor of ophthalmology and the Bascom Palmer scientist whose research has demonstrated the efficacy of MANF in experimental models of retinal degeneration. “The next step will be to develop the proper method of delivering it to the back of the eye.”
http://med.miami.edu/news/bascom-palmer-licen...ch-company
Soluble MANF is already patented for other uses. Seems this would be an easy means of application to the eye, too.
New MANF ocular orphan indication coming no later than October 6th from Neuroassets. Any guesses?
“We are quite excited about the possibilities for MANF,” said Rong Wen, M.D., Ph.D., professor of ophthalmology and the Bascom Palmer scientist whose research has demonstrated the efficacy of MANF in experimental models of retinal degeneration. “The next step will be to develop the proper method of delivering it to the back of the eye.”
http://med.miami.edu/news/bascom-palmer-licen...ch-company
Soluble MANF is already patented for other uses. Seems this would be an easy means of application to the eye, too.
New MANF ocular orphan indication coming no later than October 6th from Neuroassets. Any guesses?
(0)
(0)
